Contineum Therapeutics, Inc. (CTNM)
17.05
-0.20
(-1.16%)
USD |
NASDAQ |
Aug 28, 16:00
17.05
0.00 (0.00%)
After-Hours: 18:54
Contineum Therapeutics Price to Book Value : 2.676 for Aug. 28, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 27, 2026 | 2.707 |
| August 26, 2026 | 2.671 |
| August 25, 2026 | 2.676 |
| August 24, 2026 | 2.61 |
| August 21, 2026 | 2.698 |
| August 20, 2026 | 2.514 |
| August 19, 2026 | 2.514 |
| August 18, 2026 | 2.276 |
| August 17, 2026 | 2.280 |
| August 14, 2026 | 2.227 |
| August 13, 2026 | 2.401 |
| August 12, 2026 | 2.351 |
| August 11, 2026 | 2.326 |
| August 10, 2026 | 2.274 |
| August 07, 2026 | 2.360 |
| August 06, 2026 | 2.409 |
| August 05, 2026 | 2.396 |
| August 04, 2026 | 2.495 |
| August 03, 2026 | 2.500 |
| July 31, 2026 | 2.431 |
| July 30, 2026 | 2.472 |
| July 29, 2026 | 2.257 |
| July 28, 2026 | 2.222 |
| July 27, 2026 | 2.175 |
| July 24, 2026 | 2.207 |
| Date | Value |
|---|---|
| July 23, 2026 | 2.255 |
| July 22, 2026 | 2.312 |
| July 21, 2026 | 2.182 |
| July 20, 2026 | 2.124 |
| July 17, 2026 | 2.233 |
| July 16, 2026 | 2.199 |
| July 15, 2026 | 2.296 |
| July 14, 2026 | 2.287 |
| July 13, 2026 | 2.294 |
| July 10, 2026 | 2.384 |
| July 09, 2026 | 2.425 |
| July 08, 2026 | 2.456 |
| July 07, 2026 | 2.285 |
| July 06, 2026 | 2.437 |
| July 02, 2026 | 2.370 |
| July 01, 2026 | 2.392 |
| June 30, 2026 | 2.572 |
| June 29, 2026 | 2.243 |
| June 26, 2026 | 2.122 |
| June 25, 2026 | 1.998 |
| June 24, 2026 | 1.917 |
| June 23, 2026 | 1.781 |
| June 22, 2026 | 1.737 |
| June 18, 2026 | 1.785 |
| June 17, 2026 | 1.818 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Cocrystal Pharma, Inc. | 14.66 |
| CNBX Pharmaceuticals, Inc. | -- |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | 1.065 |
| Fulcrum Therapeutics, Inc. | 0.9465 |
Price to Book Value Related Metrics
| Price | 17.05 |
| Earnings Yield | -10.19% |
| Market Cap | 641.31M |